Global, strategic, consulting practice for Start-ups, M&A, Turnaround, and Market EntryClients and partners include: - Manufacturing - R&D and go to market strategies for global filtration and membrane manufacturer- Pharma - CRO, Clinical Trial, IND, FDA in oncology and anti-infective therapies (multiple clients)- HealthTech - Device and therapeutics, clinical validation, market entry- Health Informatics - App/SaaS/Platform solution. Optimization, encryption, market entry. - Travel - Health strategies for personnel and operations in passenger airline and cruise clients- Non-profit - Startup CEO for oncology research accelerator. services to partners in healthcare, technology, and transportation. Significant turnaround and business optimization experience in small, medium and very large organizations. Certified expert in corporate culture and transformationExpertise:- Fractional Executive Services: Solo or team-based- Growth / M&A / Turnaround environments- Small startup / Medium / Very large organizational experience - FDA and regulatory policy and strategies- VC / PE / JV - Data privacy (healthcare and general)- Corporate Culture certifications- Incubator / Tech-transfer operations

Partner responsible for precision medicine portfolio (global) assets. Negotiated tech-transfer MOU with National University Health System of Singapore.Contributor creating Israel public health system (Clalit) tech-transfer agreement.Fractional CEO for Clio Go (AI-powered, health apps and payments)Fractional CEO for Medstatix (Verified healthcare service review)Clinical advisor for Venture Labs and iLab. Led FDA facility and 510(k) Class I products (Software as Medical Device) registrations.

Led re-design of UPMC "HealthPlaNET" Population Health Management technology platform.Managed $120M venture investmentAccountable for identifying incubators, market targets, revenue/ROI.Integrated 40+ UPMC Insurance and Hospital system 40+ care-management platformsUnified technology platform into single, SaaS, web solution with real-time actionable dataLed development of UPMC Hospitals RevCycle software replacementInnovated first "zero down-time" technologies for UPMC care management assetsMaintained 100% "on time" deployment and budget control during pandemic

Turnaround CEO Molecular Diagnostics "Next-Gen Sequencing" Company Oncology, solid tumors, ~500 gene target panelClosed failed Series A round Negotiated penalty warrants off cap tableRaised $16.8M Series B round including Arsenal capitalDeployed new Illumina sequencing technology platformCreated new quantitative / annotation / curation platformsRestructured operations and technology, streamlined staffReduced COGS 75%Increased throughput and accuracyCreated first Sales and Marketing staff, with national deploymentCreated Joint Ventures with:1. Denka (Japan) - (eventual acquirer)2. Genomic Expressions (Denmark)3. CancerHope (Israel)

Founding Chair: Population HealthChair: Clinical Management SupportManaged: Enterprise Business Intelligence Led Continuous Improvement, Healthcare Outcomes, & Project Management business units Consolidated 6 operating units; Eliminated 17% top-line expense.Part of Cleveland Clinic Executive Management team - Responsible for global systems operations

Executive ManagementResponsibilities for enterprise level:- Operations- Clinical affairs- Analytics, outcomes, and research. Executive sponsor for key clientOrganizational liaison: Media, trade groups, media, government (US and OUS), and academic institutionsSupported leadership in: - Product- Sales- Client Services- Legal and Regulatory Affairs. Strategic planning for new business and technology opportunities

Executive Management team member.Enterprise responsibilities: Medical Directors; Clinical Affairs; Operations; Analytics; Outcomes Reporting ;Quality ;Integrity ;Pharmacy; and Research.OperationsLead business unit integration and consolidation, achieving operational efficiency, coordination of resources, and over 10% reduction in costs. Reporting structure included approximately 2,500 individuals.

Executive Management Responsibilities: - Operations- Medical Directors and Care Management Clinicians and programs.- Quality, Compliance, and CertificationsDirect support:- Product development- Customer and sales relations- Market / media / academic interactions

Led entire team of medical directors for all clinical areasResponsible for managing enterprise Oncology case management programsDeveloped advanced Oncology care guidelinesSupported sales and client services for US and international clients

Responsible for DM/CM/UM Oncology GuidelinesOncology case reviewLed care management nurse activitiesSupported Sales and Client Services

Beaumont Health Executive ManagementDeveloped integrated multidisciplinary breast care programDeployed program across all system three hospitalsExpanded Fellowship training programCreated and deployed SaaS Electronic Health and Billing assetsResponsible for quality and reportingFounding faculty member Oakland University Medical School

Academic and Clinical Faculty in the school of medicine (formerly UMDNJ - Robert Wood Johnson);Faculty of the Rutgers Cancer Institute of New Jersey, an NCI Comprehensive Cancer Center.

Staff surgeon providing general surgery and surgical oncology care to the Veterans of North-central Florida

Surgery and Cancer Center Faculty with diverse surgical practice in Gastrointestinal, Endocrine, Soft-tissue Sarcoma, and Breast Oncology

Assistant Chief of Surgery; Surgical Oncology Fellowship